Transcept Pharmaceuticals Inc (NASDAQ:TSPT) is a speciality pharmaceutical company focused on the development of products that address the therapeutic needs in the field of neuroscience. At present the company has a market capitalization of $66.3 million and an average daily volume of 150,580 shares.
Also see: How Doing What Is Right Helped Build the Indian Financial System
Transcept Pharmaceuticals offers deep value
Currently, Transcept Pharmaceuticals Inc (NASDAQ:TSPT) offers deep value, as the company is trading below the value of its cash balance. Indeed, at the end of the fiscal third quarter, Transcept reported cash and short-term investments of just under $76 million, worth around $4.02 per share. The only liabilities that the...
Login required to continue reading.
Setup a free account to get access to this article (no credit card required).
View Full Article
